Page last updated: 2024-08-18

methyleugenol and Intestinal Diseases

methyleugenol has been researched along with Intestinal Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
El-Shorbagy, HM; Saleh, H	1

Other Studies

1 other study(ies) available for methyleugenol and Intestinal Diseases

Article	Year
Mechanism underlying methyl eugenol attenuation of intestinal ischemia/reperfusion injury. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 2017, Volume: 42, Issue:10 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biomarkers; Caspase 3; Disease Models, Animal; Eugenol; Inflammation Mediators; Interleukin-6; Intestinal Diseases; Intestinal Mucosa; Intestines; Male; Oxidative Stress; Rats, Wistar; Reperfusion Injury; RNA, Messenger; Signal Transduction; Tumor Necrosis Factor-alpha	2017

Article

Year

Mechanism underlying methyl eugenol attenuation of intestinal ischemia/reperfusion injury.

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 2017, Volume: 42, Issue:10

Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biomarkers; Caspase 3; Disease Models, Animal; Eugenol; Inflammation Mediators; Interleukin-6; Intestinal Diseases; Intestinal Mucosa; Intestines; Male; Oxidative Stress; Rats, Wistar; Reperfusion Injury; RNA, Messenger; Signal Transduction; Tumor Necrosis Factor-alpha

2017